concept

CYTOKINES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CYTOKINES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4386Connections

0Hypotheses

3Analyses

50Outgoing

50Incoming

0Experiments

Summary

CYTOKINES is a concept in neurodegeneration research. Key relationships include: activates, inhibits, therapeutic target. Associated with ALS, Aging, Als. Connected to 2296 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	CYTOKINES
Key Genes/Proteins	INFLAMMATION, PROINFLAMMATORY CYTOKINES, NF-ΚB
Related Diseases	Inflammation, Als, Tumor, Autoimmune, Cancer
Related Pathways	Nf-Κb

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

→

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

→

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

→

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        CYTOKINES["CYTOKINES"] -->|"associated with"| INFLAMMATION["INFLAMMATION"]
    end
    subgraph Signaling["Signaling"]
        CYTOKINES["CYTOKINES"] -->|"activates"| PROINFLAMMATORY_CYTOKINES["PROINFLAMMATORY CYTOKINES"]
        CYTOKINES["CYTOKINES"] -->|"activates"| Tumor["Tumor"]
        NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| CYTOKINES["CYTOKINES"]
        PI3K["PI3K"] -->|"activates"| CYTOKINES["CYTOKINES"]
        PI3K_2["PI3K"] -.->|"inhibits"| CYTOKINES["CYTOKINES"]
        CANCER["CANCER"] -->|"regulates"| CYTOKINES["CYTOKINES"]
        ERK["ERK"] -->|"activates"| CYTOKINES["CYTOKINES"]
    end
    subgraph Therapeutic["Therapeutic"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| INFLAMMATION_1["INFLAMMATION"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| NF__B["NF-KappaB"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| Inflammation["Inflammation"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| Als["Als"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| Autoimmune["Autoimmune"]
        CYTOKINES["CYTOKINES"] -->|"therapeutic target"| Nf__b["Nf-Kappab"]
        PI3K_3["PI3K"] -->|"therapeutic target"| CYTOKINES["CYTOKINES"]
    end
    style CYTOKINES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PROINFLAMMATORY_CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style INFLAMMATION_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NF__B fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Tumor fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autoimmune fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Nf__b fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURODEGENERATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PI3K fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PI3K_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CANCER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ERK fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PI3K_3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2811)

Target	Relation	Type	Str
INFLAMMATION	associated_with	gene	1.00
PROINFLAMMATORY CYTOKINES	activates	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
NF-ΚB	therapeutic_target	gene	1.00
Inflammation	therapeutic_target	disease	1.00
Als	therapeutic_target	disease	1.00
Tumor	activates	disease	1.00
Autoimmune	therapeutic_target	disease	1.00
Nf-Κb	therapeutic_target	pathway	1.00
INFLAMMATION	inhibits	gene	1.00
NF-ΚB	inhibits	gene	1.00
Inflammation	inhibits	disease	1.00
Cancer	inhibits	disease	1.00
Tumor	inhibits	disease	1.00
Nf-Κb	inhibits	pathway	1.00
PROINFLAMMATORY CYTOKINES	inhibits	gene	1.00
MITOCHONDRIAL DYSFUNCTION	activates	gene	1.00
AUTOPHAGY	activates	gene	1.00
NEUROINFLAMMATION	activates	gene	1.00
Als	activates	disease	1.00
Neuroinflammation	activates	disease	1.00
Inflammation	activates	disease	1.00
Autophagy	activates	pathway	1.00
AKT	activates	gene	1.00
Neurodegeneration	activates	disease	1.00
Mtor	activates	pathway	1.00
AKT	inhibits	gene	1.00
NF-ΚB	activates	gene	1.00
Nf-Κb	activates	pathway	1.00
Mapk	activates	pathway	1.00
ASTROCYTES	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
Alzheimer	activates	disease	1.00
Als	expressed_in	disease	1.00
Phagocytosis	activates	pathway	1.00
Mitophagy	activates	pathway	1.00
IL-6	inhibits	gene	1.00
TNF-Α	inhibits	gene	1.00
Als	inhibits	disease	1.00
INFLAMMATION	regulates	gene	1.00
NF-ΚB	regulates	gene	1.00
IL-6	activates	gene	1.00
NEUROINFLAMMATION	regulates	gene	1.00
TNF-Α	activates	gene	1.00
Inflammation	regulates	disease	1.00
Neuroinflammation	regulates	disease	1.00
Nf-Κb	regulates	pathway	1.00
Apoptosis	activates	pathway	1.00
Immune Response	activates	pathway	1.00
Oxidative Stress	activates	pathway	1.00

Incoming (1575)

Source	Relation	Type	Str
NEURODEGENERATION	activates	gene	1.00
PI3K	activates	gene	1.00
PI3K	inhibits	gene	1.00
CANCER	regulates	gene	1.00
ERK	activates	gene	1.00
PI3K	therapeutic_target	gene	1.00
PARKINSON'S DISEASE	activates	gene	1.00
STAT3	activates	gene	1.00
NLRP3	activates	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
CANCER	therapeutic_target	gene	1.00
ALZHEIMER	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
PARKINSON	activates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
INFLAMMATION	regulates	gene	1.00
TNF	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
APOPTOSIS	inhibits	gene	1.00
TNF	inhibits	gene	1.00
NEURODEGENERATION	implicated_in	gene	1.00
ROS	activates	gene	1.00
NEUROTOXICITY	activates	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
MITOPHAGY	activates	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
COMPLEMENT	activates	gene	1.00
PYROPTOSIS	activates	gene	1.00
EXERCISE	activates	gene	1.00
ROS	inhibits	gene	1.00
TNF	expressed_in	gene	1.00
NLRP3	inhibits	gene	1.00
TNF	regulates	gene	1.00
APOPTOSIS	therapeutic_target	gene	1.00
Tetrahydroxy Stilbene Glucoside	suppresses	compound	0.90
BAX	inhibits	gene	0.90
PARKINSON'S DISEASE	therapeutic_target	gene	0.90
ERK	therapeutic_target	gene	0.90
CANCER	activates	gene	0.90
TLR4	activates	gene	0.90
MIRNAS	regulates	gene	0.90
CANCER	associated_with	gene	0.90
PI3K	regulates	gene	0.90
STROKE	activates	gene	0.90
PROINFLAMMATORY CYTOKINES	activates	gene	0.90
INFLAMMATION	inhibits	gene	0.90
DEMENTIA	activates	gene	0.90
TNF	associated_with	gene	0.90
AUTOPHAGY	activates	gene	0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

CYTOKINES

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Pathway Diagram

Outgoing (2811)

Incoming (1575)

Targeting Hypotheses (0)

Mentioning Analyses (3)

Systemic immune profiling in neurodegeneration: peripheral inflammation as drive

Neuroinflammation and microglial priming in early AD

Neuroinflammation and microglial priming in early Alzheimer's Disease

Experiments (0)

Related Papers (0)

CYTOKINES

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

Atypical Parkinsonism

Device Therapies Comparison for CBS/PSP

Parthanatos in Neurodegeneration

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

PD Combination Therapy Matrix

Corticobasal Degeneration (CBD)

nhp-validation-animal-model

nimodipine-als

Neuroresilience Mechanisms and Evidence

Pathway Diagram

Outgoing (2811)

Incoming (1575)

Targeting Hypotheses (0)

Mentioning Analyses (3)

Systemic immune profiling in neurodegeneration: peripheral inflammation as drive

Neuroinflammation and microglial priming in early AD

Neuroinflammation and microglial priming in early Alzheimer's Disease

Experiments (0)

Related Papers (0)